Aventis Sues To Block Sanofi Bid; N.J. Suit Suggests All Politics Is Local
This article was originally published in The Tan Sheet
Executive Summary
Sanofi's plan to extract significant "synergies" from the proposed acquisition of Aventis would mean heavy cuts in the U.S., Aventis maintains in a lawsuit seeking to block the takeover bid
You may also be interested in...
Novartis, Aventis Begin Merger Talks; Sanofi Considers Raising Bid
Sanofi will continue to evaluate the market response to its tender offer for Aventis before deciding whether to sweeten its bid, CFO Marie-Helene Laimay said during a first quarter investor call April 22
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands